Protease cleavage of iron-transferrin augments pyocyanin-mediated endothelial cell injury via promotion of hydroxyl radical formation

Infection and Immunity

Volumn 64, Issue 1, 1996, Pages 182-188

  Miller, Rachel A ^a,b   Rasmussen, George T ^a,b   Cox, Charles D ^b   Britigan, Bradley E ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; DEFEROXAMINE; DIMETHYL SULFOXIDE; DIMETHYLTHIOUREA; HYDROGEN PEROXIDE; HYDROXYL RADICAL; PROTEINASE; PYOCYANINE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TRANSFERRIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; ENDOTHELIUM INJURY; ENZYME MODIFICATION; ENZYME SPECIFICITY; IRON CHELATION; NONHUMAN; OXIDATION REDUCTION REACTION; PATHOGENESIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PULMONARY ARTERY; SWINE;

EID: 0030045473     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.1.182-188.1996     Document Type: Article

References (67)

1. Amitani, R., R. Wilson, A. Rutman, R. Read, C. Ward, D. Burnett, R. A. Stockley, and P. J. Cole. 1991 Effects of human neutrophil elastase and Pseudomonas aerugmosa proteinases on human respiratory epithelium Am J Respir. Cell Mol Biol. 4:26-32.
2. Armstrong, A. V., D. E. S. Stewart-Tull, and J. S. Roberts. 1971 Characterisation of the Pseudomonas aeruginosa factor that inhibits mouse-liver mitochondrial respiration. J. Med. Microbiol. 4:249-262
3. Aruoma, O. I., and B. Halliwell. 1987. Superoxide-dependent and ascorbate-dependent formation of hydroxyl radicals from hydrogen peroxide in the presence of iron Are lactoferrin and transferrin promoters of hydroxylradical generation? Biochem. J. 241:273-278.
4. Baldwin, D. A., E. R. Jenny, and P. Aisen. 1984 The effect of human serum transferrin and milk lactoferrin on hydroxyl radical formation from superoxide and hydrogen peroxide. J. Biol. Chem 259:13391-13394.
5. Bedrossian, C. W. M., S. D. Greenberg, D. B. Singer, J. J. Hansen, and H. S. Rosenberg. 1976. The lung in cystic fibrosis. A quantitative study including prevalence of pathologic findings among different age groups. Hum. Pathol. 7:195-204.
6. Bluard-Deconinck, J., J. Williams, R. W. Evans, J. van Snick, P. A. Osinski, and P. L. Masson. 1978 Iron-binding fragments from the N-terminal and C-terminal regions of human lactoferrin. Biochem. J. 171:321-327
7. Bodey, G. P., R. Bolivar, V. Fainstein, and L. Jadeja. 1983 Infections caused by Pseudomonas aeruginosa. Rev. Infect. Dis. 5:279-313.
8. Brines, R. D., and J. H. Brock. 1983. The effect of trypsin and chymotrypsin on the in vitro antimicrobial and iron-binding properties of lactoferrin in human milk and bovine colostrum: unusual resistance of human apolactoferrin to proteolytic digestion Biochim. Biophys. Acta 759:229-235
9. Britigan, B. E., and B. L. Edeker. 1991. Pseudomonas and neutrophil products modify transferrin and lactoferrin to create conditions that favor hydroxyl radical formation. J. Clin. Invest 88:1092-1102.
10. Britigan, B. E., M. B. Hayek, B. N. Doebbeling, and R. B. Fick, Jr. 1993. Transferrin and lactoferrin undergo proteolytic cleavage in the Pseudomonas aeruginosa-infected lungs of patients with cystic fibrosis. Infect. Immun. 61:5049-5055.
11. Britigan, B. E., G. T. Rasmussen, and C. D. Cox. 1994. Pseudomonas siderophore pyochelin enhances neutrophil-mediated endothelial cell injury Am. J. Physiol. 266:L192-L198.
12. Britigan, B. E., T. L. Roeder, and D. M. Shasby. 1992. Insight into the nature and site of oxygen-centered free radical generation by endothelial cell monolayers using a novel spin trapping technique. Blood 79:699-707.
13. Britigan, B. E., G. M. Rosen, Y. Chai, and M. S. Cohen. 1986. Do human neutiophils make hydroxyl radical? Detection of free radicals generated by human neutrophils activated with a soluble or particulate stimulus using electron paramagnetic resonance spectrometry J Biol. Chem. 261:4426-4431.
14. Bruce, M. C., L. Ponez, J. D. Klinger, R. C. Stern, J. F. Tomashefski, Jr., and D. G. Dearborn. 1985 Biochemical and pathologic evidence for proteolytic destruction of lung connective tissue in cystic fibrosis. Am. Rev. Respir. Dis. 132:529-535
15. Buettner, G. R. 1987. The reaction of superoxide, formate radical, and hydrated electron with transferrin and its model compound, Fe(III)-ethylenediamine-N.N'-bis [2-(2-hydroxyphenyl) acetic acid] as studied by pulse radiolysis. J. Biol. Chem. 262:11995-11998
16. Bullen, J. J., H. J. Rogers, and E. Griffiths. 1978 Role of iron in bacterial infection Curr. Top. Microbiol. Immunol. 80:1-35.
17. Busch, C., P. A. Cancilla, L. E. DeBault, J. C. Goldsmith, and W. G. Owen. 1982. Use of endothelium cultured on microcarriers as a model for the microcirculation. Lab. Invest. 47:498-504.
18. Cabelli, D. E., D. Allen, B. H. J. Bielski, and J. Holeman. 1988. The interaction between Cu(I) superoxide dismutase and hydrogen peroxide. J Biol. Chem. 264:9967-9971.
19. Cash, H. A., D. E. Woods, B. McCullough, W. G. Johanson, and J. A. Bass. 1979 A rat model of chronic respiratory infection with Pseudomonas aeruginosa. Am. Rev Respir. Dis. 119:453-459.
20. Cox, C. D. 1986. Role of pyocyanin in the acquisition of iron from transferrin. Infect Immun. 52:263-270
21. Cross, C. E., B. Halliwell, E. T. Borish, W. A. Pryor, R. L. Saul, J. M. McCord, and D. Harman. 1987. Oxygen radicals and human disease. Ann. Intern. Med. 107:526-545.
22. Doring, G., W. Goldstein, A. Roll, P. O. Schiotz, N. Hoiby, and K. Botzenhart. 1985 Role of Pseudomonas aeruginosa exoenzymes in lung infections of patients with cystic fibrosis. Infect. Immun 49:557-562
23. Doring, G., H.-J. Obernesser, K. Botzenhart, B. Flehmig, N. Hoiby, and A. Hofmann. 1983 Proteases of Pseudomonas aeruginosa in patients with cystic fibrosis. J. Infect. Dis. 147:744-750.
24. Doring, G., M. Pfestorf, K. Botzenhart, and M. A. Abdallah. 1988. Impact of proteases on iron uptake of Pseudomonas aeruginosa pyoverdin from transferrin and lactoferrin Infect. Immun. 56:291-293
25. Dunn, M. M., M. Dunne, and D. W. Kamp. 1990. Polymorphonuclear leukocyte- and Pseudomonas aeruginosa-induced damage to a human pulmonary epithelial cell line. J Infect Dis. 162:172-177.
26. Esparza, I., and J. H. Brock. 1980 The effect of trypsin digestion on the structure and iron-donating properties of transferring from several species. Biochim. Biophys Acta 622:297-307
27. Evans, R. W., and J. Williams. 1978 Studies of the binding of different iron donors to human serum transferrin and isolation of iron-binding fragments from the N- and C-terminal regions of the protein. Biochem. J. 173:543-552.
28. Fick, R. B., Jr. 1989. Pathogenesis of the Pseudomonas lung lesion in cystic fibrosis Chest 96:158-164.
29. Fick, R. B., Jr., and J. S. Hata. 1989. Pathogenetic mechanisms in lung disease caused by Pseudomonas aeruginosa. Chest 95:2065-2135.
30. Fick, R. B., Jr., G. P. Naegel, S. U. Squier, R. E. Wood, J. B. L. Gee, and H. V. Reynolds. 1984. Proteins of the cystic fibrosis respiratory tract' fragmented immunoglobulin G opsonic antibody causing defective opsonuphagocytosis. J Clin Invest 74:236-248.
31. Friedheim, E. A. H. 1934. XXV. The effect of pyocyanine on the respiration of some normal tissues and tumours. Biochem. J. 28:173-179.
32. Goldstein, W., and G. During. 1986. Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis. Am. Rev. Respir. Dis. 134:49-56.
33. Gutteridge, J. M. C., S. K. Paterson, A. W. Segal, and B. Halliwell. 1981 Inhibition of lipid peroxidation by the iron-binding protein lactoferrin. Biochem. J. 199:259-261.
34. Hassan, H. M., and I. Fridovich. 1980. Mechanism of the antibiotic action of pyocyanine J Bacteriol. 141:156-163.
35. Hatanaka, M., and K. Tsuboi. 1991. Initiation of wound healing by proteinases released from damaged cells. Int. J Tissue React 13(5):249-255.
36. Heffner, J. E., and J. E. Repine. 1989. Pulmonary strategies of antioxidant defense. Am. Rev. Respir Dis. 140:531-554
37. Holder, I. A. 1983 Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: effect of treatment with protease inhibitors. Rev. Infect. Dis. 5:S914-S921.
38. Jackson, A. H., S. L. Hill, S. C. Afford, and R. A. Stockley. 1984. Sputum sol-phase proteases and elastase activity in patients with cystic fibrosis. Eur. J. Respir Dis. 65:114-124.
39. Kreger, A. S. 1983. Pathogenesis of Pseudomonas aeruginosa ocular disease. Rev. Infect. Dis 5:S931-S935.
40. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227:680-685.
41. Legrand, D., J. Mazurier, J. Montreuil, and G. Spik. 1988. Structure and spatial conformation of the iron-binding sites of transferrins. Biochimie 70:1185-1195
42. Line, W. F., D. A. Sly, and A. Bezkorovainy. 1976. Limited cleavage of human lactoferrin with pepsin. Int. J. Biochem. 9:203-208.
43. Masson, P. L., J. F. Heremans, and C. H. Dive. 1966. Studies on lactoferrin, an iron-binding protein common to many external secretions. Clin. Chim Acta 14:735-739.
44. 1-antiprotease complex in cystic fibrosis: comparison with interstitial lung disease and evaluation of the effect of intravenously administered antibiotic therapy. Am. Rev. Respir. Dis. 144:580-585.
45. Miller, R. A., and B. E. Britigan. 1995 Protease cleaved iron-transferrin augments oxidant-mediated endothelial cell injury via hydroxyl radical formation J Clin. Invest. 95:2491-2500.
46. Mohammed, J. R., B. S. Mohammed, L. J. Pawluk, D. M. Bucci, N. R. Baker, and W. B. Davis. 1988. Purification and cytotoxic potential of myeloperoxidase in cystic fibrosis sputum. J. Lab Clin. Med. 112:711-720.
47. Munro, N. C., A. Barker, A. Rutman, G. Taylor, D. Watson, W. J. McDonald-Gibson, R. Towart, W. A. Taylor, R. Wilson, and P. J. Cole. 1989 Effect of pyocyanin and 1-hydroxyphenazine on in vivo tracheal mucus velocity. J. Appl. Physiol. 67:316-323
48. Pennington, J. P. 1990. 280 Nosocomial respiratory infection, p. 2199-2205. In G. L. Mandell, R G. Douglas, Jr., and J. E Bennett (ed.), Principles and practice of infectious diseases, 2nd ed. Churchill Livingstone, New York
49. Pier, G. B. 1985. Pulmonary disease associated with Pseudomonas aeruginosa in cystic fibrosis. Current status of the host bacterium interaction. J. Infect. Dis. 151:515-580.
50. Ramos, C. L., S. Pou, B. E. Britigan, M. S. Cohen, and G. M. Rosen. 1492. Spin trapping evidence for myeloperoxidase-dependent hydroxyl radical formation by human neutrophils and monocytes. J. Biol. Chem. 267:8307-8312.
51. Reichart, E., P. Boerkmann, and F. Plenat. 1992. Parenteral administration of tiypsin triggers lung emphysema. Eur. Respir J. 5:810-814.
52. Reynolds, H. Y. 1987. Bronchoalveolar lavage. Am. Rev. Respir Dis 135:250-263.
53. Russell, R. M. 1992. 200 Nutritional assessment, p. 1154 In J. B. Wyngaarden, L. H. Smith, Jr , and J. C. Bernett (ed.), Cecil textbook of medicine, 19th ed. W B. Saunders Co., Philadelphia.
54. Shellito, J., S. Nelson, and R. U. Sorensen. 1992. Effect of pyocyanine, a pigment of Pseudomonas aeruginosa, on production of reactive nitrogen intermediates by murine alveolar macrophages. Infect. Immun. 60:3913-3915.
55. Sibille, Y., and H. Y. Reynolds. 1990. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am. Rev. Respir. Dis. 141:471-501.
56. Stern, R. C., R. E. Wood, T. F. Boat, L. W. Matthews, A. S. Tucker, and C. F. Doershuk. 1978. Treatment and prognosis of massive hemoptysis in cystic fibrosis. Am Rev. Respir. Dis. 117:825-828.
57. Stone, P. J., C. Franzblau, and H. M. Kagan. 1982. Proteolysis of insoluble elastin Methods Enzymol. 82:588-592.
58. Suter, S. 1989. The imbalance between granulocyte neutral proteases and antiproteases in bronchial secretions from patients with cystic fibrosis Antibiot. Chemother. 42:158-168.
59. Suter, S., O. B. Schaad, L. Roux, U. E. Nydegger, and F. A. Waldvogel. 1934. Granulocyte neutral proteases and Pseudomonas elastase as possible causes of airway damage in patients with cystic fibrosis. J. Infect. Dis. 149:523-531
60. Suter, S., O. B. Schaad, H. Tegner, K. Ohlsson, D. Desgrandchamps, and F. A. Waldvogel. 1986. Levels of free granulocyte elastase in bronchial secretions from patients with cystic fibrosis. J. Infect. Dis. 153:902-909.
61. Ward, P. A. 1991. Mechanisms of endothelial cell injury. J. Lab. Clin Med. 118:421-426.
62. Ward, P. A., G. O. Till, R. Kunkel, and C. Beauchamp. 1983. Evidence for the role of hydroxyl radical in complement and neutrophil-dependent tissue injury. J. Clin. Invest 72:789-801.
63. Weiss, S. J. 1986. Oxygen, ischemia and inflammation. Acta Physiol. Scand. 548(Suppl.):9-37.
64. Wilson, R., T. Pitt, G. Taylor, D. Watson, J. MacDermot, D. Sykes, D. Roberts, and P. Cole. 1987. Pyocyanin and 1-hydroxyphenazine produced by Pseudomonas aeruginosa inhibit the beating of human respiratory cilia in vitro. J Clin Invest. 79:221-229.
65. Wilson, R., D. A. Sykes, D. Watson, A. Rutman, G. W. Taylor, and P. J. Cole. 1988. Measurement of Pseudomonas aeruginosa phenazine pigments in sputum and assessment of their contribution to sputum sol toxicity for respiratory epithelium. Infect. Immun. 56:2515-2517.
66. Winterbourn, C. C. 1983. Lactoferrin-catalyzed hydroxyl radical production: additional requirements for a chelating agent. Biochem J. 210:15-19.
67. Wretlind, B., and O. R. Pavlovskis. 1983. Pseudomonas elastase and its role in pseudomonas infections. Rev. Infect. Dis. 5:S998-S1004.